The Value of Anti-Drug Antibody Detection in Discriminating Patients from Healthy Controls and Predicting the Gross Motor Functional State in Patients with Pompe Disease
Iran J Allergy Asthma Immunol. 2026 Feb 1;25(2):212-221. doi: 10.18502/ijaai.v25i2.20800.ABSTRACTAnti-recombinant human acid α-glucosidase (anti-rhGAA) antibody formation is a major challenge in patients with Pompe disease receiving enzyme replacement therapy (ERT). The clinical significance of thes

